Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer

Authors

S. Adams, V. Diéras, C.H. Barrios, E.P. Winer, A. Schneeweiss, H. Iwata, S. Loi, S. Patel, V. Henschel, S.Y. Chui, H.S. Rugo, L.A. Emens, P. Schmid